聚焦于肿瘤消融及免疫治疗的基础和临床研究工作👨🏻🍼，取得系列创新性成果。迄今以第一/通讯作者在 Nature Communications（IF= 17.694，2篇）💂🏿、Advanced Functional Materials（IF= 19.924）💁🏻、Advanced Science（IF= 17.521👮🏻，2篇）、ACS Nano（IF= 18.027）、Journal of Clinical Endocrinology & Metabolism（IF= 6.134） 等国际知名学术期刊共发表 SCI 论文 14 篇⚧，影响因子总和 100 余，其中影响因子10分以上6篇👧🏼🧮， 1 篇为ESI高被引论文。2019年获亚太肿瘤介入大会（APCIO 2019）青年学者一等奖；2020年获上海“医树奖”青年临床医学科技创新奖🙍🏽♂️。主持国家自然科学基金青年、面上项目以及上海市科委、上海市卫健委等项目 5 项，在研经费超过150万🍉🔽。
代表性论文（*共同通讯作者）：
[1] Yue W, Chen L, Yu L, Zhou B, Yin H, Ren W, Liu C, Guo L, Zhang Y, Sun L, Zhang K*, Xu H*, Chen Y*. Checkpoint blockade and nanosonosensitizer augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice. Nat Commun, 2019, 10(1): 2025. (SCI, IF=17.694, ESI高被引)
[2] Guan X, Sun L, Shen Y, Jin F, Bo X, Zhu C, Han X, Li X, Chen Y*, Xu H*, Yue W*. Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post- surgical cancer recurrence and metastasis. Nat Commun, 2022;13(1):2834. (SCI, IF=17.694)
[3] Shen Y, Chen L, Guan X, Han X, Bo X, Li S, Sun L, Chen Y*, Yue W*, Xu H*. Tailoring Chemoimmunostimulant Bioscaffolds for Inhibiting Tumor Growth and Metastasis after Incomplete Microwave Ablation. ACS Nano, 2021, 15(12): 20414-20429. (SCI, IF=18.027）
[4] Li S, Zhu C, Zhou X, Chen L, Bo X, Shen Y, Guan X, Han X, Shan D, Sun L, Chen Y*, Xu H*, Yue W*. Engineering ROS-Responsive Bioscaffolds for Disrupting Myeloid Cell-Driven Immunosuppressive Niche to Enhance PD-L1 Blockade-Based Postablative Immunotherapy. Adv Sci (Weinh), 2022, 13: e2104619. (SCI, IF=17.521）
[5] Zhang K*, Li HY, Lang JY, Li XT, Yue WW*, Yin YF, Du D, Fang Y, Wu H, Zhao YX*, Xu C*. Quantum Yield‐Engineered Biocompatible Probes Illuminate Lung Tumor Based on Viscosity Confinement‐Mediated Antiaggregation. Adv Funct Mater, 2019, 29(44): 1905124. (SCI, IF=19.924）
[6] Yue WW#, Qi L#, Wang DD, Yu SJ, Wang XJ, Xu HX*, Wang SR*. US-guided Microwave Ablation of Low-Risk Papillary Thyroid Microcarcinoma: Longer-Term Results of a Prospective Study. Journal of Clinical Endocrinology & Metabolism, 2020, 105(6): dgaa128. (SCI, IF= 6.134🫁，内分泌领域TOP期刊)
